The myotonic dystrophy health index: Japanese adaption and validity testing-Reference-Cited by-同舟云学术

The myotonic dystrophy health index: Japanese adaption and validity testing

Published:2019-02-08 Issue:5 Volume:59 Page:577-582
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Mori Itsuki¹,Fujino Haruo²³^ORCID,Matsumura Tsuyoshi⁴,Takada Hiroto⁵,Ogata Katsuhisa⁶,Nakamori Masayuki⁷,Innami Keisuke⁸⁹,Shingaki Honoka³,Imura Osamu³,Takahashi Masanori P.¹⁷^ORCID,Heatwole Chad¹⁰

Affiliation:

1. Department of Functional Diagnostic ScienceOsaka University Graduate School of Medicine 1‐7 Yamadaoka Suita Osaka 565‐0871 Japan

2. Department of Special Needs EducationOita University Oita Japan

3. Graduate School of Human SciencesOsaka University Suita Japan

4. Department of NeurologyNational Hospital Organization Toneyama National Hospital Toyonaka Japan

5. Department of NeurologyNational Hospital Organization Aomori National Hospital Aomori Japan

6. Department of NeurologyNational Hospital Organization Higashisaitama National Hospital Hasuda Japan

7. Department of NeurologyOsaka University Graduate School of Medicine Suita Japan

8. International and Translational Medicine ProgramOsaka University Graduate School of Medicine Suita Japan

9. Knowledge Capital Association Osaka Japan

10. Department of NeurologyUniversity of Rochester Medical Center Rochester New York USA

Funder

NCNP

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.26422

Reference25 articles.

1. U.S. FoodandDrug Administration.Guidance for industry and FDA staff Qualification process for drug development tools.2014. Available athttps://www.fda.gov/ucm/groups/fdagov‐public/@fdagov‐drugs‐gen/documents/document/ucm230597.pdf. Accessed December 14 2018.

2. Myotonic Dystrophy Health Index: Initial evaluation of a disease-specific outcome measure

3. Myotonic dystrophy health index: Correlations with clinical tests and patient function

4. Myotonic dystrophy patient preferences in patient‐reported outcome measures;Heatwole C;Muscle Nerve

5. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facioscapulohumeral muscular dystrophy Health Index: Japanese translation and validation study;Disability and Rehabilitation;2024-03-31

2. Qualidade dos instrumentos que avaliam Atividade e Participação de pessoas com distrofia muscular: uma revisão sistemática de medidas de resultado relatadas pelos pacientes;Developmental Medicine & Child Neurology;2022-08-08

3. Quality of instruments assessing activity and participation of people with muscular dystrophy: A systematic review of participant‐reported outcome measures;Developmental Medicine & Child Neurology;2022-07-21

4. The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure;Journal of Huntington's Disease;2022-06-03

5. Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1;BMC Neurology;2022-02-14